(b) Short time horizon may not capture full costs and effects of the intervention. Lack of detailed medical resource use data. Within-trial analysis and so does not reflect full body of available evidence for all comparators; FAIR-HF is one of 4 studies comparing IV iron to no iron treatment. Chronic Heart Failure Treating Heart Failure NICE 2018. All rights reserved. Subject to Notice of rights. ISBN: 978-1-4731-3093-7 Unit costs Relevant unit costs of oral and intravenous iron are provided below to aid consideration of cost effectiveness. Oral iron The cost of oral iron therapy was taken from the Drug Tariff, May 2016240 with the number of tablets prescribed estimated from the Prescription Cost Analysis, July 2016.143 Table 56 below, shows a weighted average of the 2 most commonly prescribed tablets. Table 56: Cost of oral iron therapy Drug Tablets Cost per tablet ( ) Tablets per day Cost per month ( ) Weighted average 5.70 Intravenous iron These costs were updated from the NICE clinical guideline entitled Anaemia management in people with chronic kidney disease (AMCKD) (NG8). In the AMCKD guideline, cost was estimated based on: drug cost, staff time, clinical space, administrator time, and transport. Detail regarding the sources and assumptions used for costing are outlined below. Staff time was estimated by the committee members and the infusion time dependent on drug SPCs. Observation (30 minutes) is required for all regimens. It was assumed that a nurse would observe 2 patients concurrently. The cost of a band 6 nurse at a rate of 51 per hour was applied80 . 